Loading…
Cognitive Decline in Severe Intractable Epilepsy
Purpose: To explore the relation between seizure‐related variables and cognitive change in patients with severe intractable epilepsy. Methods: A retrospective analysis of data from 136 patients who had undergone a cognitive assessment on two occasions at an interval of ≥10 years. Cognitive measures...
Saved in:
Published in: | Epilepsia (Copenhagen) 2005-11, Vol.46 (11), p.1780-1787 |
---|---|
Main Authors: | , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c5729-be5691a6a2276ab413e09dba4cf4863e74e7a62cff856ced3ba9ba3a8ad103583 |
---|---|
cites | cdi_FETCH-LOGICAL-c5729-be5691a6a2276ab413e09dba4cf4863e74e7a62cff856ced3ba9ba3a8ad103583 |
container_end_page | 1787 |
container_issue | 11 |
container_start_page | 1780 |
container_title | Epilepsia (Copenhagen) |
container_volume | 46 |
creator | Thompson, Pamela J. Duncan, John S. |
description | Purpose: To explore the relation between seizure‐related variables and cognitive change in patients with severe intractable epilepsy.
Methods: A retrospective analysis of data from 136 patients who had undergone a cognitive assessment on two occasions at an interval of ≥10 years. Cognitive measures included tests of memory and executive skills in addition to intelligence quotients (IQ). Details were available regarding seizure type and frequency in the intertest interval.
Results: Cognitive decline was severe and occurred across a wide range of cognitive functions. The frequency of generalised tonic–clonic seizures was the strongest predictor of decline. Complex partial seizure frequency was associated with a decline in memory and executive skills but not in IQ. Seizure‐related head injuries and advancing age carried a poor cognitive prognosis, whereas periods of remission were associated with a better cognitive outcome. Early age at onset was not implicated, and duration of epilepsy was a much less potent predictor of cognitive decline than has been reported in cross‐sectional studies. No evidence indicated that a higher level of cognitive function protected against cognitive decline.
Conclusions: Our findings, together with those from animal studies and surgically treated patients, suggest that seizures can have a direct adverse effect on cognition and that good seizure control even after years of intractability can have a beneficial impact on cognitive prognosis. This study was based on individuals who merited two cognitive assessments ≥10 years apart and hence is biased in favor of those with the most severe forms of refractory epilepsy and those with decline. |
doi_str_mv | 10.1111/j.1528-1167.2005.00279.x |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68821192</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68821192</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5729-be5691a6a2276ab413e09dba4cf4863e74e7a62cff856ced3ba9ba3a8ad103583</originalsourceid><addsrcrecordid>eNqNkEtPwkAQgDdGI4j-BdOL3lpnd7uPJl4MopKQaKKeN9NlakpKwS4g_HuLEDnqXGaS-eaRj7GIQ8LbuJkkXAkbc65NIgBUAiBMlqyPWPe3ccy6AFzGmbLQYWchTADAaCNPWYdrCcIq22XQn33U5aJcUXRPvipriso6eqUVNRQN60WDfoF5RdFgXlY0D5tzdlJgFehin3vs_WHw1n-KR8-Pw_7dKPbKiCzOSemMo0YhjMY85ZIgG-eY-iK1WpJJyaAWviis0p7GMscsR4kWxxyksrLHrnd7583sc0lh4aZl8FRVWNNsGZy2VnCeiT9BAZkwXKsWtDvQN7MQGircvCmn2GwcB7fV6iZua89t7bmtVvej1a3b0cv9jWU-pfFhcO-xBa72AAaPVdFg7ctw4IyUVqe65W533Fdrc_PvB9zgZdgW8huCOpGm</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>20927165</pqid></control><display><type>article</type><title>Cognitive Decline in Severe Intractable Epilepsy</title><source>Wiley:Jisc Collections:Wiley Read and Publish Open Access 2024-2025 (reading list)</source><creator>Thompson, Pamela J. ; Duncan, John S.</creator><creatorcontrib>Thompson, Pamela J. ; Duncan, John S.</creatorcontrib><description>Purpose: To explore the relation between seizure‐related variables and cognitive change in patients with severe intractable epilepsy.
Methods: A retrospective analysis of data from 136 patients who had undergone a cognitive assessment on two occasions at an interval of ≥10 years. Cognitive measures included tests of memory and executive skills in addition to intelligence quotients (IQ). Details were available regarding seizure type and frequency in the intertest interval.
Results: Cognitive decline was severe and occurred across a wide range of cognitive functions. The frequency of generalised tonic–clonic seizures was the strongest predictor of decline. Complex partial seizure frequency was associated with a decline in memory and executive skills but not in IQ. Seizure‐related head injuries and advancing age carried a poor cognitive prognosis, whereas periods of remission were associated with a better cognitive outcome. Early age at onset was not implicated, and duration of epilepsy was a much less potent predictor of cognitive decline than has been reported in cross‐sectional studies. No evidence indicated that a higher level of cognitive function protected against cognitive decline.
Conclusions: Our findings, together with those from animal studies and surgically treated patients, suggest that seizures can have a direct adverse effect on cognition and that good seizure control even after years of intractability can have a beneficial impact on cognitive prognosis. This study was based on individuals who merited two cognitive assessments ≥10 years apart and hence is biased in favor of those with the most severe forms of refractory epilepsy and those with decline.</description><identifier>ISSN: 0013-9580</identifier><identifier>EISSN: 1528-1167</identifier><identifier>DOI: 10.1111/j.1528-1167.2005.00279.x</identifier><identifier>PMID: 16302858</identifier><identifier>CODEN: EPILAK</identifier><language>eng</language><publisher>350 Main Street , Malden , MA 02148 , USA and 9600 Garsington Road , Oxford , OX4 2XG , England: Blackwell Science Inc</publisher><subject>Adult ; Anticonvulsants. Antiepileptics. Antiparkinson agents ; Biological and medical sciences ; Cognition Disorders - diagnosis ; Cognition Disorders - epidemiology ; Cognitive decline ; Comorbidity ; Epilepsy ; Epilepsy - diagnosis ; Epilepsy - epidemiology ; Epilepsy - therapy ; Epilepsy, Tonic-Clonic - diagnosis ; Epilepsy, Tonic-Clonic - epidemiology ; Epilepsy, Tonic-Clonic - therapy ; Female ; Follow-Up Studies ; Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy ; Humans ; Intelligence ; Longitudinal Studies ; Magnetic Resonance Imaging ; Male ; Medical sciences ; Nervous system (semeiology, syndromes) ; Neurology ; Neuropharmacology ; Neuropsychological Tests - statistics & numerical data ; Neurosurgery ; Pharmacology. Drug treatments ; Prognosis ; Regression Analysis ; Retrospective Studies ; Seizures ; Severity of Illness Index ; Skull, brain, vascular surgery ; Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases ; Syncope - diagnosis ; Syncope - epidemiology ; Treatment Outcome ; United Kingdom - epidemiology</subject><ispartof>Epilepsia (Copenhagen), 2005-11, Vol.46 (11), p.1780-1787</ispartof><rights>2006 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5729-be5691a6a2276ab413e09dba4cf4863e74e7a62cff856ced3ba9ba3a8ad103583</citedby><cites>FETCH-LOGICAL-c5729-be5691a6a2276ab413e09dba4cf4863e74e7a62cff856ced3ba9ba3a8ad103583</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=17338646$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16302858$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Thompson, Pamela J.</creatorcontrib><creatorcontrib>Duncan, John S.</creatorcontrib><title>Cognitive Decline in Severe Intractable Epilepsy</title><title>Epilepsia (Copenhagen)</title><addtitle>Epilepsia</addtitle><description>Purpose: To explore the relation between seizure‐related variables and cognitive change in patients with severe intractable epilepsy.
Methods: A retrospective analysis of data from 136 patients who had undergone a cognitive assessment on two occasions at an interval of ≥10 years. Cognitive measures included tests of memory and executive skills in addition to intelligence quotients (IQ). Details were available regarding seizure type and frequency in the intertest interval.
Results: Cognitive decline was severe and occurred across a wide range of cognitive functions. The frequency of generalised tonic–clonic seizures was the strongest predictor of decline. Complex partial seizure frequency was associated with a decline in memory and executive skills but not in IQ. Seizure‐related head injuries and advancing age carried a poor cognitive prognosis, whereas periods of remission were associated with a better cognitive outcome. Early age at onset was not implicated, and duration of epilepsy was a much less potent predictor of cognitive decline than has been reported in cross‐sectional studies. No evidence indicated that a higher level of cognitive function protected against cognitive decline.
Conclusions: Our findings, together with those from animal studies and surgically treated patients, suggest that seizures can have a direct adverse effect on cognition and that good seizure control even after years of intractability can have a beneficial impact on cognitive prognosis. This study was based on individuals who merited two cognitive assessments ≥10 years apart and hence is biased in favor of those with the most severe forms of refractory epilepsy and those with decline.</description><subject>Adult</subject><subject>Anticonvulsants. Antiepileptics. Antiparkinson agents</subject><subject>Biological and medical sciences</subject><subject>Cognition Disorders - diagnosis</subject><subject>Cognition Disorders - epidemiology</subject><subject>Cognitive decline</subject><subject>Comorbidity</subject><subject>Epilepsy</subject><subject>Epilepsy - diagnosis</subject><subject>Epilepsy - epidemiology</subject><subject>Epilepsy - therapy</subject><subject>Epilepsy, Tonic-Clonic - diagnosis</subject><subject>Epilepsy, Tonic-Clonic - epidemiology</subject><subject>Epilepsy, Tonic-Clonic - therapy</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy</subject><subject>Humans</subject><subject>Intelligence</subject><subject>Longitudinal Studies</subject><subject>Magnetic Resonance Imaging</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Nervous system (semeiology, syndromes)</subject><subject>Neurology</subject><subject>Neuropharmacology</subject><subject>Neuropsychological Tests - statistics & numerical data</subject><subject>Neurosurgery</subject><subject>Pharmacology. Drug treatments</subject><subject>Prognosis</subject><subject>Regression Analysis</subject><subject>Retrospective Studies</subject><subject>Seizures</subject><subject>Severity of Illness Index</subject><subject>Skull, brain, vascular surgery</subject><subject>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</subject><subject>Syncope - diagnosis</subject><subject>Syncope - epidemiology</subject><subject>Treatment Outcome</subject><subject>United Kingdom - epidemiology</subject><issn>0013-9580</issn><issn>1528-1167</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><recordid>eNqNkEtPwkAQgDdGI4j-BdOL3lpnd7uPJl4MopKQaKKeN9NlakpKwS4g_HuLEDnqXGaS-eaRj7GIQ8LbuJkkXAkbc65NIgBUAiBMlqyPWPe3ccy6AFzGmbLQYWchTADAaCNPWYdrCcIq22XQn33U5aJcUXRPvipriso6eqUVNRQN60WDfoF5RdFgXlY0D5tzdlJgFehin3vs_WHw1n-KR8-Pw_7dKPbKiCzOSemMo0YhjMY85ZIgG-eY-iK1WpJJyaAWviis0p7GMscsR4kWxxyksrLHrnd7583sc0lh4aZl8FRVWNNsGZy2VnCeiT9BAZkwXKsWtDvQN7MQGircvCmn2GwcB7fV6iZua89t7bmtVvej1a3b0cv9jWU-pfFhcO-xBa72AAaPVdFg7ctw4IyUVqe65W533Fdrc_PvB9zgZdgW8huCOpGm</recordid><startdate>200511</startdate><enddate>200511</enddate><creator>Thompson, Pamela J.</creator><creator>Duncan, John S.</creator><general>Blackwell Science Inc</general><general>Blackwell</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7X8</scope></search><sort><creationdate>200511</creationdate><title>Cognitive Decline in Severe Intractable Epilepsy</title><author>Thompson, Pamela J. ; Duncan, John S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5729-be5691a6a2276ab413e09dba4cf4863e74e7a62cff856ced3ba9ba3a8ad103583</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Adult</topic><topic>Anticonvulsants. Antiepileptics. Antiparkinson agents</topic><topic>Biological and medical sciences</topic><topic>Cognition Disorders - diagnosis</topic><topic>Cognition Disorders - epidemiology</topic><topic>Cognitive decline</topic><topic>Comorbidity</topic><topic>Epilepsy</topic><topic>Epilepsy - diagnosis</topic><topic>Epilepsy - epidemiology</topic><topic>Epilepsy - therapy</topic><topic>Epilepsy, Tonic-Clonic - diagnosis</topic><topic>Epilepsy, Tonic-Clonic - epidemiology</topic><topic>Epilepsy, Tonic-Clonic - therapy</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy</topic><topic>Humans</topic><topic>Intelligence</topic><topic>Longitudinal Studies</topic><topic>Magnetic Resonance Imaging</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Nervous system (semeiology, syndromes)</topic><topic>Neurology</topic><topic>Neuropharmacology</topic><topic>Neuropsychological Tests - statistics & numerical data</topic><topic>Neurosurgery</topic><topic>Pharmacology. Drug treatments</topic><topic>Prognosis</topic><topic>Regression Analysis</topic><topic>Retrospective Studies</topic><topic>Seizures</topic><topic>Severity of Illness Index</topic><topic>Skull, brain, vascular surgery</topic><topic>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</topic><topic>Syncope - diagnosis</topic><topic>Syncope - epidemiology</topic><topic>Treatment Outcome</topic><topic>United Kingdom - epidemiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Thompson, Pamela J.</creatorcontrib><creatorcontrib>Duncan, John S.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Epilepsia (Copenhagen)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Thompson, Pamela J.</au><au>Duncan, John S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cognitive Decline in Severe Intractable Epilepsy</atitle><jtitle>Epilepsia (Copenhagen)</jtitle><addtitle>Epilepsia</addtitle><date>2005-11</date><risdate>2005</risdate><volume>46</volume><issue>11</issue><spage>1780</spage><epage>1787</epage><pages>1780-1787</pages><issn>0013-9580</issn><eissn>1528-1167</eissn><coden>EPILAK</coden><abstract>Purpose: To explore the relation between seizure‐related variables and cognitive change in patients with severe intractable epilepsy.
Methods: A retrospective analysis of data from 136 patients who had undergone a cognitive assessment on two occasions at an interval of ≥10 years. Cognitive measures included tests of memory and executive skills in addition to intelligence quotients (IQ). Details were available regarding seizure type and frequency in the intertest interval.
Results: Cognitive decline was severe and occurred across a wide range of cognitive functions. The frequency of generalised tonic–clonic seizures was the strongest predictor of decline. Complex partial seizure frequency was associated with a decline in memory and executive skills but not in IQ. Seizure‐related head injuries and advancing age carried a poor cognitive prognosis, whereas periods of remission were associated with a better cognitive outcome. Early age at onset was not implicated, and duration of epilepsy was a much less potent predictor of cognitive decline than has been reported in cross‐sectional studies. No evidence indicated that a higher level of cognitive function protected against cognitive decline.
Conclusions: Our findings, together with those from animal studies and surgically treated patients, suggest that seizures can have a direct adverse effect on cognition and that good seizure control even after years of intractability can have a beneficial impact on cognitive prognosis. This study was based on individuals who merited two cognitive assessments ≥10 years apart and hence is biased in favor of those with the most severe forms of refractory epilepsy and those with decline.</abstract><cop>350 Main Street , Malden , MA 02148 , USA and 9600 Garsington Road , Oxford , OX4 2XG , England</cop><pub>Blackwell Science Inc</pub><pmid>16302858</pmid><doi>10.1111/j.1528-1167.2005.00279.x</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0013-9580 |
ispartof | Epilepsia (Copenhagen), 2005-11, Vol.46 (11), p.1780-1787 |
issn | 0013-9580 1528-1167 |
language | eng |
recordid | cdi_proquest_miscellaneous_68821192 |
source | Wiley:Jisc Collections:Wiley Read and Publish Open Access 2024-2025 (reading list) |
subjects | Adult Anticonvulsants. Antiepileptics. Antiparkinson agents Biological and medical sciences Cognition Disorders - diagnosis Cognition Disorders - epidemiology Cognitive decline Comorbidity Epilepsy Epilepsy - diagnosis Epilepsy - epidemiology Epilepsy - therapy Epilepsy, Tonic-Clonic - diagnosis Epilepsy, Tonic-Clonic - epidemiology Epilepsy, Tonic-Clonic - therapy Female Follow-Up Studies Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy Humans Intelligence Longitudinal Studies Magnetic Resonance Imaging Male Medical sciences Nervous system (semeiology, syndromes) Neurology Neuropharmacology Neuropsychological Tests - statistics & numerical data Neurosurgery Pharmacology. Drug treatments Prognosis Regression Analysis Retrospective Studies Seizures Severity of Illness Index Skull, brain, vascular surgery Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases Syncope - diagnosis Syncope - epidemiology Treatment Outcome United Kingdom - epidemiology |
title | Cognitive Decline in Severe Intractable Epilepsy |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T01%3A42%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cognitive%20Decline%20in%20Severe%20Intractable%20Epilepsy&rft.jtitle=Epilepsia%20(Copenhagen)&rft.au=Thompson,%20Pamela%20J.&rft.date=2005-11&rft.volume=46&rft.issue=11&rft.spage=1780&rft.epage=1787&rft.pages=1780-1787&rft.issn=0013-9580&rft.eissn=1528-1167&rft.coden=EPILAK&rft_id=info:doi/10.1111/j.1528-1167.2005.00279.x&rft_dat=%3Cproquest_cross%3E68821192%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c5729-be5691a6a2276ab413e09dba4cf4863e74e7a62cff856ced3ba9ba3a8ad103583%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=20927165&rft_id=info:pmid/16302858&rfr_iscdi=true |